ROUTINELY AVAILABLE NONINVASIVE TESTS DISCRIMINATE ADVANCED FIBROSIS DUE TO NASH IN THE PHASE 3 STELLAR TRIALS OF THE ASK1 INHIBITOR SELONSERTIB

Wong, Vincent Wai-SunAnstee, QuentinLawitz, EricAlkhouri, NaimRomero-Gomez, ManuelOkanoue, TakeshiTrauner, MichaelKersey, KathrynLi, GeorgiaSubramanian, ManiMyers, RobertDjedjos, StephenHan, LingTuan NguyenKohli, AnitaBzowej, NatalieYounes, ZiadSarin, ShivShiffman, MitchellHarrison, StephenGoodman, ZacharyYounossi, Zobair2025-01-072025-01-072019-06-010017-5749https://hdl.handle.net/10668/27316enROUTINELY AVAILABLE NONINVASIVE TESTS DISCRIMINATE ADVANCED FIBROSIS DUE TO NASH IN THE PHASE 3 STELLAR TRIALS OF THE ASK1 INHIBITOR SELONSERTIBconference outputopen access10.1136/gutjnl-2019-IDDFabstracts.2671468-3288https://gut.bmj.com/content/gutjnl/68/Suppl_1/A136.full.pdf472085300264